4.8 Article

The landscape of cancer cell line metabolism

Journal

NATURE MEDICINE
Volume 25, Issue 5, Pages 850-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41591-019-0404-8

Keywords

-

Funding

  1. NCI Cancer Center Support Grant [NIH 5 P30 CA06516]
  2. Novartis
  3. R35 Outstanding Investigator Award from the National Cancer Institute
  4. NCI's Cancer Target Discovery and Development (CTD2) Network [U01 CA217848]
  5. [U01 CA176058]

Ask authors/readers for more resources

Despite considerable efforts to identify cancer metabolic alterations that might unveil druggable vulnerabilities, systematic characterizations of metabolism as it relates to functional genomic features and associated dependencies remain uncommon. To further understand the metabolic diversity of cancer, we profiled 225 metabolites in 928 cell lines from more than 20 cancer types in the Cancer Cell Line Encyclopedia (CCLE) using liquid chromatography-mass spectrometry (LC-MS). This resource enables unbiased association analysis linking the cancer metabolome to genetic alterations, epigenetic features and gene dependencies. Additionally, by screening barcoded cell lines, we demonstrated that aberrant ASNS hypermethylation sensitizes subsets of gastric and hepatic cancers to asparaginase therapy. Finally, our analysis revealed distinct synthesis and secretion patterns of kynurenine, an immune-suppressive metabolite, in model cancer cell lines. Together, these findings and related methodology provide comprehensive resources that will help clarify the landscape of cancer metabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available